Answers are grounded in this paper and cite their sources.
Hypertension is commonly associated with chronic kidney disease (CKD) and is a key mediator of progressive kidney damage and the associated increase in cardiovascular mortality1.The importance of blood pressure (BP) control as a therapeutic intervention in CKD, both for reduction in mortality and progression of kidney disease, is well established 2,3 but many patients do not achieve their BP targets4. The optimum BP target is debated, especially following the cardiovascular benefit shown by targeting a lower systolic BP of <120mmHg in the Systolic Blood Pressure Intervention Trial (SPRINT)S1.
No takes yet. Share an insight, caveat, or question.
Lucas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: